Computational study reveals isomer-dependent intersystem crossing mechanisms in carbazole-benzoate isomers, indicating distinct spin-vibronic pathways drive similar overall transition rates.
We investigate the intersystem crossing (ISC) mechanism of three isomeric molecules, namely, methyl 2-(9H-carbazol-9-yl)benzoate (o-MCBA), methyl 3-(9H-carbazol-9-yl)benzoate (m-MCBA), and methyl 4-(9H-carbazol-9-yl)benzoate (p-MCBA). Our analyses highlight the role of direct spin-orbit (DSO) coupling, Herzberg-Teller (HT) coupling, and spin-vibronic (SV) coupling in facilitating the ISC processes in these molecules. We have found that the dominant ISC pathway between the lowest excited singlet state (SCT1o/p) having charge-transfer (CT) character and the triplet state (TCT1+LE1o/p) with mixed CT and locally excited (LE) characters is primarily governed by both DSO and HT interactions in o-MCBA and p-MCBA, whereas for m-MCBA, the ISC pathway between the lowest excited singlet state (SLE1m) and the triplet state (TLE1m) is mainly assisted by HT and SV interactions. The time-dependent correlation function based method has been employed for the calculations of ISC rate constant (kISC). The computed DSO/HT assisted kISCs for the ISC pathway involving the lowest excited singlet and the triplet states of ortho, para, and meta isomers are found to be 0.87 × 106/4.16 × 106, 1.18 × 106/2.24 × 106, and 5.67 × 103/4.02 × 106 s-1, respectively, while the SV-aided kISC of m-MCBA is turned out to be 5.45 × 106 s-1. Our theoretical analysis reveals that while the SV interaction plays a crucial role on the ISC mechanism of meta isomer, the larger energy gaps between the lowest excited singlet state (SCT1o/p) and the higher lying triplet state (TCT2+LE2o/p) as well as that between (TCT2+LE2o/p) and the lowest excited triplet state (TCT1+LE1o/p) suppress the SV-driven ISC processes in ortho and para isomers. This study emphasizes that the origins of the same order of the experimental kISCs of the structural isomers are completely different.
No takes yet. Share an insight, caveat, or question.
Karak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: